Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis. - Boot AM; Ariceta G; Beck-Nielsen SS; Brandi ML; Briot K; Collantes CL; Giannini S; Haffner D; Keen R; Levtchenko E; Mughal MZ; Mäkitie O; et al. (Therapeutic advances in chronic disease, 2024)